News & Updates
Filter by Specialty:
Triplet regimen works against triple-negative breast cancer
08 Jul 2022
Treatment with a novel combination of famitinib, camrelizumab, and nab-paclitaxel appears safe and effective in patients with advanced immunomodulatory triple-negative breast cancer (TNBC), as shown in the results of the phase II FUTURE-C-Plus trial.
Triplet regimen works against triple-negative breast cancer
08 Jul 2022
CVD prevention better with ACE inhibitor–statin combo than monotherapy
08 Jul 2022
In patients with hypertension, combined treatment with angiotensin-converting enzyme (ACE) inhibitors plus statins reduces the risk of developing cardiovascular disease (CVD) at a greater magnitude as compared with ACE inhibitor monotherapy, a study has found.
CVD prevention better with ACE inhibitor–statin combo than monotherapy
08 Jul 2022
Age the biggest risk factor for COVID-19 mortality in haematological cancer patients
07 Jul 2022
byRoshini Claire Anthony
A study conducted in England has shown that in patients with haematological malignancy, the risk of COVID-19–related mortality is greatly influenced by age.